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Abstract
Non-enveloped viruses penetrate host membranes to infect cells. A cell-based assay was used to probe the endoplasmic
reticulum (ER)-to-cytosol membrane transport of the non-enveloped SV40. We found that, upon ER arrival, SV40 is released
into the lumen and undergoes sequential disulfide bond disruptions to reach the cytosol. However, despite these ER-
dependent conformational changes, SV40 crosses the ER membrane as a large and intact particle consisting of the VP1 coat,
the internal components VP2, VP3, and the genome. This large particle subsequently disassembles in the cytosol. Mutant
virus and inhibitor studies demonstrate VP3 and likely the viral genome, as well as cellular proteasome, control ER-to-cytosol
transport. Our results identify the sequence of events, as well as virus and host components, that regulate ER membrane
penetration. They also suggest that the ER membrane supports passage of a large particle, potentially through either a
sizeable protein-conducting channel or the lipid bilayer.
Citation: Inoue T, Tsai B (2011) A Large and Intact Viral Particle Penetrates the Endoplasmic Reticulum Membrane to Reach the Cytosol. PLoS Pathog 7(5):
e1002037. doi:10.1371/journal.ppat.1002037
Editor: Denise Galloway, Fred Hutchinson Cancer Research Center, United States of America
Received October 10, 2010; Accepted March 7, 2011; Published May 12, 2011
Copyright:  2011 Inoue, Tsai. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Support was provided by the NIH/NIAID grant AI064296 (BT). The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: btsai@umich.edu
Introduction
The mechanism by which non-enveloped viruses such as simian
virus 40 (SV40) and the murine polyomavirus (mPy) penetrate the
host cell’s membrane to cause infection is enigmatic. However, a
general model describing how they breach this membrane based
largely on in vitro studies is emerging [1,2]. In this model, the virus
undergoes conformational changes by interacting with host factors,
culminatingintheformationofahydrophobicviralparticleorrelease
of a lytic peptide. They then engage the limiting membrane to disrupt
its integrity, enabling the virus to cross the membrane. As it is
unknown whether this scenario reflects the pathway in cells,
establishing a cell-based assay that monitors non-enveloped virus
membrane penetration affords the opportunity to study this event’s
physiological mechanism.Importantquestionsinclude:what reaction
sequence initiates membrane penetration? What is the nature of the
viral conformational change and identity of the membrane
penetrating species? What viral and host components control the
penetration process, and how is membrane transport achieved?
Here we address SV40’s membrane transport process. Struc-
turally, SV40 is composed of 72 pentamers of the VP1 coat
assembled into an icosahedral viral capsid [3,4]. Each VP1
pentamer engages the internal proteins VP2 and VP3 through
hydrophobic interactions [5]. VP1 also binds to the ,5 kb viral
DNA genome buried within the virus through electrostatic
interactions. Three additional forces support the overall viral
architecture. First, disulfide bonds present throughout the virus
stabilize it [4]. Second, the VP1 C-terminus invades a neighboring
VP1 pentamer to provide inter-pentamer support [3]. And third,
calciums bound to the virus clamp together different pentamers to
increase capsid stabilization [4].
To infect cells, SV40 VP1 binds to the glycolipid ganglioside
GM1 on the host cell surface [6], inducing membrane tubulation
that initiates internalization [7]. The virus-receptor complex is
then transported to the pH neutral caveosomes [8] or the low pH
endolysosomes [9]. Regardless of the pathway, the virus
subsequently sorts to the endoplasmic reticulum (ER). Upon
arrival of the virus-receptor complex to the ER [10], SV40 is
proposed to disassemble to cross the ER membrane and reach the
cytosol [11]. From the cytosol, a subviral core particle transports
into the nucleus where transcription and replication of the viral
DNA ensue, leading to lytic infection or cell transformation.
Reactions controlling SV40’s ER-to-cytosol transport, a decisive
infection event, are not fully understood. How do ER-initiated
events propel the virus to the cytosol? What is the identity of the
membrane penetrating species? What viral, ER, and cytosolic
components regulate this process? While a report suggests that the
ER associated degradation (ERAD) machinery mediates SV40
infection [12], how this machinery geared normally to handle
endogenous proteins much smaller than SV40 (,50 nm in
diameter) promotes membrane transport of the larger viral
particle is unclear.
Here we established a cell-based assay to elucidate SV40’s ER-
to-cytosol membrane penetration. Our data demonstrate that,
upon ER arrival, SV40 is released into the ER lumen and
undergoes sequential disulfide bond modification as it moves to the
cytosol. Despite these reactions, a large and intact SV40
intermediate penetrates the ER membrane to reach the cytosol
where it disassembles. We also pinpoint viral and host components
that regulate the penetration process. This assay thus provides the
opportunity to illuminate SV40’s membrane penetration mecha-
nism in a cellular setting.
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Establishment of a cell based ER-to-cytosol membrane
penetration assay for SV40
We first tested whether brefeldin A (BFA), a drug that can
impede COPI-dependent retrograde transport from the cell
surface to the ER, blocks arrival of SV40 to the ER and infection
as reported previously [11,13]. A convenient method to measure
SV40 ER arrival is to monitor conformational changes imparted
on the virus in the ER. For instance, when SV40 arrives in the ER,
ER-resident protein disulfide isomerase (PDI) family members
disrupt its disulfide bonds [12]. When a whole cell extract (WCE)
derived from infected cells was analyzed by non-reducing SDS-
PAGE, VP1 monomer was detected [12]. Accordingly, simian
CV-1 cells were incubated with SV40 (m.o.i. 30) for 12 hrs at
37uC. The cells were solubilized with SDS to generate a WCE,
and the samples analyzed by non-reducing SDS-PAGE followed
by immunoblotting with VP1-specific antibodies. We detected
formation of both VP1 monomer and a species whose size
corresponds to a VP1 dimer (Figure 1A, lane 1). An additional
VP1 species at the top of the gel was also detected, which is likely
derived from the intact virus. The VP1 monomer and dimer levels
decreased when cells were treated with BFA at infection (0 h.p.i.)
(Figure 1A, compare lane 2 to 1). A similar VP1 monomer level
was observed when the samples were subjected to reducing SDS-
PAGE (Figure 1A, compare lanes 3 and 4).
BFA was added to cells 4 hrs post infection (4 h.p.i.) to avoid
perturbing viral entry. After 8 additional hrs, cells were harvested
and analyzed as above. Under this condition, we found that the
VP1 monomer and dimer levels also decreased when compared to
control cells (Figure S1A, top panel, compare lane 2 to 1),
indicating that BFA likely acted at an intracellular step required
for ER sorting. Analyses using confocal microscopy further
demonstrated that when cells were treated with BFA 4 h.p.i., co-
localization between SV40 (green) and ER (red) decreased (Figure
S1B, compare right and left panels). Collectively, these results
indicate that ER transport is required to generate VP1 monomer
and dimer.
To assess BFA’s effect on viral infection, control and BFA-
treated cells were incubated with SV40, and immunofluorescence
microscopy was used to score expression of the virally encoded T
antigen (TAg) in the nucleus as before [14]. We found that BFA
decreased SV40 infection potently (Figure 1B). This result
demonstrates that ER transport is critical for SV40 infection,
consistent with previous observations [11,13]. Thus BFA blocks
SV40 trafficking to the ER and infection.
To establish an ER-to-cytosol transport assay for SV40, outlined
in Figure 1C, we modified our semi-permeabilized cell-based assay
developed previously to probe translocation of cholera toxin (CT)
from the ER to the cytosol [15]. In this modified assay, SV40-
infected CV-1 cells were treated with a low digitonin concentra-
tion (0.1%) to gently permeabilize the plasma membrane while
leaving intracellular membranes, including the ER membrane,
intact (Figure 1C, step 1). The permeabilized cells were
centrifuged at medium-speed (16,000 g) to generate two fractions:
a supernatant fraction (S1) that should contain cytosolic proteins,
virus that reached the cytosol from the ER, and any endosomal
vesicles harboring virus that did not sediment at the medium-speed
spin, and a pellet fraction (P1) that should contain the plasma
membrane, intracellular organelles including the ER and nucleus,
and SV40 that either did not undergo ER-to-cytosol transport or
did but is further imported into the nucleus. P1 contents were
extracted by Triton X-100 and SDS. When S1 and P1 were
subjected to reducing SDS-PAGE followed by immunoblotting,
we found the cytosolic marker Hsp90 is predominantly in the S1
(Figure 1D, compare second and fifth panels from top), while the
ER lumenal protein PDI was present only in the P1 (Figure 1D,
compare 6
th and 3
rd panels from top). Similar to Hsp90, the
cytosolic protein actin also appeared in S1 but not P1 using this
fractionation method (Figure S1C, top and bottom panels,
compare lane 1 to 2). Hence, this one-step fractionation procedure
efficiently separates cytosolic from ER contents, similar to our
previous report [15].
When cells were incubated with wild-type (WT) SV40 at 4uC, a
condition that blocks endocytosis, and the cells subjected to the
fractionation procedure, no VP1 was detected in the S1
(Figure 1D, lane 1, compare first and fourth panels from top). In
contrast, when the cells were incubated with SV40 at 37uC for
8 hrs (8 h.p.i.) to allow entry, a portion of VP1 was found in the S1
(Figure 1D, lane 2, compare first and fourth panels from top).
When cells treated with BFA at infection (0 h.p.i.) were incubated
with SV40 at 37uC for 8 hrs, the VP1 level present in the S1
decreased (Figure 1D, top panel, compare lanes 3 to 2). Similar
results were observed when cells were incubated with SV40 at
37uC for 10 hrs and 12 hrs: for both time points, appearance of
SV40 in the S1 was blocked significantly by BFA (Figure 1D, top
panel, compare lanes 5 to 4 and lanes 7 to 6). Moreover, when
BFA was added to cells 4 h.p.i. and the cells harvested after 8
additional hours, the S1 VP1 level also decreased significantly
(Figure 1E, top panel, compare lane 2 to 1). Thus, by blocking ER
arrival (Figure 1A, S1A, and S1B), BFA also attenuates the
subsequent ER-to-cytosol transport of SV40.
We showed previously that BFA also blocked ER-to-cytosol
transport of CT [15,16]. To intoxicate cells, CT via its B subunit
(CTB) binds to GM1 on the cell surface, becomes rapidly
endocytosed into invaginating vesicles, transported to the early
and recycling endosomes, then followed by retrograde sorting
through the Golgi and to the ER [17]. In the ER, the catalytic
CTA1 undergoes ER-to-cytosol translocation to reach the cytosol
where the toxin induces cytotoxicity. We had demonstrated that
BFA blocked ER-to-cytosol transport of CTA1 in both HeLa [15]
and 293T [16] cells. Here, when CV-1 cells treated with BFA at
intoxication were subjected to the semi-permeabilized assay
(Figure 1C), the S1 CTA1 level (analyzed 90 min post-intoxication)
Author Summary
Biological membranes represent a major barrier during
viral infection. While the mechanism by which an
enveloped virus breaches the limiting membrane of a
host cell is well-characterized, this membrane penetration
process is poorly understood for non-enveloped viruses.
Indeed, most available insights on membrane transport of
non-enveloped viruses are built upon in vitro studies. Here
we established a cell-based assay to elucidate the
molecular mechanism by which the non-enveloped SV40
penetrates the endoplasmic reticulum (ER) membrane to
access the cytosol, a critical step in infection. Strikingly, we
uncovered SV40 breaches the ER membrane as a large and
intact viral particle, despite the conformational changes it
experiences in the ER lumen. This result suggests that the
ER membrane can accommodate translocation of a large
protein complex, possibly through either a sizeable protein
channel or the ER membrane bilayer. In addition to this
finding, we also pinpoint viral and host components that
control the ER-to-cytosol membrane transport event.
Together, our data illuminate the cellular mechanism by
which a non-enveloped virus penetrates the limiting
membrane of a target cell during infection.
A Large SV40 Particle Penetrates the ER Membrane
PLoS Pathogens | www.plospathogens.org 2 May 2011 | Volume 7 | Issue 5 | e1002037Figure 1. Establishment of a cell-based ER-to-cytosol membrane penetration assay for SV40. (A) SV40-infected cells were treated with or
without BFA at infection (0 h.p.i.), and infection allowed for 12 hrs. WCE was prepared and analyzed by non-reducing and reducing SDS-PAGE, and
immunoblotted with an antibody against VP1. (B) Large T antigen (TAg)-positive cells were counted in SV40-infected cells treated with or without
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S1D, top panel, compare lane 1 to 2). This finding is consistent with
our previous findings [15,16] and further substantiates BFA’s ability
to generally perturb ER-to-cytosol transport processes by disrupting
ER arrival.
As SV40 also relies on a nocodazole-sensitive step to reach the
ER critical for infection [8], we showed that when cells were
treated with nocodazole at infection, the S1 VP1 level 12 h.p.i. was
blocked completely when compared to control cells (Figure 1F, top
panel, compare lane 1 to 2). Hence nocodazole effectively
perturbed SV40’s ER-to-cytosol transport, presumably by block-
ing viral transport to the ER.
A more detailed time-course experiment using the semi-
permeabilized system demonstrated that significant VP1 level
started to appear in the S1 approximately 6 h.p.i., although a low
VP1 level appeared in the S1 at 4 h.p.i. (Figure S1E, top panel).
Because a previous study demonstrated that SV40 arrives to the
ER approximately 6 h.p.i. [18], the low VP1 level in the S1 at 4
h.p.i. is unlikely virus that underwent ER-to-cytosol transport.
Instead, it may represent virus that either leaked from a membrane
compartment due to digitonin treatment or in transport vesicles en
route to the ER which did not pellet after medium-speed
centrifugation.
To test the former possibility, we asked whether digitonin causes
leakage of CTB from membrane vesicles. CTB is used because it is
much smaller than SV40, binds to ganglioside GM1 (akin to VP1),
and is also targeted to the ER similar to SV40. Accordingly, cells
were intoxicated with CT for either 5 min (where CTB is found in
vesicles/endosomes) or 90 min (where CTB is found in a mixture
of endosomes, Golgi, and ER). Following digitonin treatment, cells
were subjected to 16,000 g medium-speed centrifugation to
generate S1 (Figure S1F, see diagram and top and bottom panels,
lane 1). S1 was treated with or without 2% SDS and subjected to
high-speed centrifugation (100,000 g) to generate a supernatant
(sn) and pellet fractions. Under this condition, vesicles harboring
CTB should pellet, while CTB that leaked due to membrane
rupture by digitonin should appear in the sn. We found that, at
both time points, CTB appeared only in the pellet but not the sn
(Figure S1F, top and bottom panels, compare lane 5 to 3). If SDS
was added to S1 to artificially solubilize vesicles prior to high-speed
centrifugation, CTB appeared in the sn but not pellet instead
(Figure S1F, top and bottom panels, compare lane 6 to 4). We
conclude that digitonin treatment did not cause CTB leakage from
vesicles. Thus, because CTB is much smaller than SV40, it is
unlikely that digitonin disrupted any membrane vesicles to cause
leakage of SV40.
To test the idea that VP1 in the S1 at 4 h.p.i. represents SV40 in
transport vesicles that did not sediment after medium-speed
centrifugation, we first used limited proteolysis because this
method distinguishes between membrane-encased virus versus
naked virus. Because of the low VP1 level in the S1 at 4 h.p.i., a
higher amount of this sample was used to visualize VP1. We found
that VP1 in the S1 at 4 h.p.i. is resistant to trypsin digestion, in
contrast to virus at 12 h.p.i. (Figure S1G, compare top and bottom
panels, lanes 1 to 2 and 3). These findings indicate that SV40 in
the S1 at 4 h.p.i. is likely contained in membrane vesicles, while
those at 12 h.p.i. are not.
To further support this view, we subjected SV40 in the S1 at
both 4 and 12 h.p.i., as well as purified WT SV40, to OptiPrep
gradient flotation. The majority of VP1 at 4 h.p.i. floated to lighter
density fractions when compared to purified SV40 (Figure S1H,
compare top and bottom panels). In contrast, VP1 at 12 h.p.i.
displayed very little flotation when compared to purified SV40
(Figure S1H, compare middle and bottom panels). These results
demonstrate that the low SV40 level in the S1 at 4 h.p.i. is
membrane-bound, presumably reflecting transport vesicles carry-
ing SV40 that have not arrived to the ER. By contrast, virus at 12
h.p.i. is naked and not in vesicles, consistent with the property of a
viral particle that has penetrated the ER membrane. We conclude
that VP1 in the S1 at the 12 h.p.i. time point, as well as at the
earlier 8 and 10 h.p.i. time points (see below), represents the virus
pool that reached the cytosol from the ER.
An increase in cytosol-localized SV40 should allow more viral
particles to enter the nucleus to cause infection. We found that
increasing the m.o.i. increased both the S1 VP1 level at 12 h.p.i.
(Figure S1I, top panel, lanes 1–6) and infection (Figure S1I,
bottom graph). This correlation is consistent with the view that
virus in S1 at 12 h.p.i. represents cytosol-localized virus poised to
enter the nucleus to promote infection.
To further verify that the semi-permeabilized assay reflects
SV40’s ER-to-cytosol transport, we reasoned that down-regula-
tion of ER-resident factors implicated in SV40 infection should
block ER-to-cytosol transport as well. As ERp57 down-
regulation decreased virus infection [12], we showed that
ERp57 knock-down also decreased the S1 VP1 level at 12
h.p.i. (Figure 1G, top panel, compare lane 1 to 2). Similarly, we
found that down-regulation of a novel ER-resident DNA J
protein required for efficient SV40 infection also decreased the
amount of S1 VP1 (manuscript in preparation). Finally, as
treating cells with dithiothreitol (DTT) was shown to attenuate
infection [12], we found that DTT treatment decreased both the
S1 SV40 level (at 12 h.p.i.) and infection (Figure S1J, top panel,
compare lane 2 to 1, and right graph). These findings further
validate the semi-permeabilized system as an ER-to-cytosol
transport assay.
In CV-1 cells, the earliest expression of new VP1 occurred at
20 h.p.i. (Figure 1H, middle panel, arrow), consistent with an
earlier report in the same cell line [19]. This finding demonstrates
that VP1 in the S1 derived from cells incubated with SV40 for 8,
10, and 12 hrs (Figure 1D, top panel, lanes 2, 4, and 6) is input
but not de novo synthesized virus. We note that TAg expressed at
14 h.p.i. (Figure 1H, top panel, arrow head), suggesting that only
a small proportion of virus in the P1 at the 8, 10, and 12 h.p.i.
time points represents nuclear-localized virus. When control and
BFA-treated cells were incubated with a biotinylated SV40 for
12 hrs, and the cells subjected to the ER-to-cytosol transport
BFA at infection (0 h.p.i.), and the results reported as the % of TAg expressing cells. Data represent the mean +/2 SD of at least 3 independent
experiments. In a field of view, 345/378 cells were scored TAg-positive in control cells, while 0/344 cells were scored TAg-positive for BFA-treated
cells. (C) A schematic diagram of the ER-to-cytosol transport assay and the ensuing fractionation strategy. (D) Cells treated with or without BFA were
incubated with SV40 for the indicated amount of time and processed according to Figure 1C. 10% of P1 and 20% of S1 were loaded. (E) As in D,
except BFA was added to cells 4 h.p.i. (F) As in D, except nocodazole was added to cells 0 h.p.i. and the cells harvested 12 h.p.i. (G) Cells transfected
with either a scrambled or ERp57 siRNA were infected with SV40 for 12 hrs and processed as in D. (H) SV40-infected cells were harvested at the
indicated post-infection time points, lysed in SDS sample buffer and analyzed by immunoblotting with antibodies against TAg, VP1, and Hsp90.
Arrow head indicates the initiation time point of TAg synthesis, while arrow indicates the initiation time point of VP1 synthesis. (I) Cells treated with or
without BFA at infection were infected with SV40 for 12 hrs and processed as in D. In addition, the S1 was subjected to PCR to amplify a part of the
SV40 genome. (J) As in I except where indicated, a VP2/VP3 antibody was used.
doi:10.1371/journal.ppat.1002037.g001
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detected in the S1 derived from control and to a lesser extent
BFA-treated cells (Figure S1K, top panel, compare lane 1 to 2).
This finding further proves that the input virus reaches the
cytosol.
Do other viral components undergo ER-to-cytosol transport? In
addition to immunoblotting, the S1 from control and BFA-treated
cells infected with SV40 for 12 hrs were subjected to PCR analyses
using primers designed to amplify an SV40 genome fragment. We
found presence of the viral genome in S1 derived from control but
not BFA-treated cells (Figure 1I, top panel, compare lane 1 to 2).
Similarly, using a VP2/VP3-specific antibody, we detected VP2
and VP3 in S1 derived from control but not BFA-treated cells
(Figure 1J, top panel, compare lane 1 to 2). The higher VP3
intensity when compare to VP2 is not due to preferential antibody
binding to VP3 as VP2 contains all of VP3 except VP2 has an
additional N-terminal extension. Instead, this observation is likely
because the input SV40 particle contains more VP3 than VP2
(below), similar to a previous report [20]. These results
demonstrate that VP2, VP3, and the viral genome are co-
transported with VP1 from the ER to the cytosol.
ER-localized SV40 is released into the ER lumen, and
undergoes sequential disulfide bond disruption to reach
the cytosol
We next analyzed ER events that prime SV40 for membrane
penetration by taking further advantage of the semi-permeablized
system. We hypothesize that, upon ER arrival, SV40 remains
bound to GM1 on the lumenal surface of the ER membrane, as
the related mPy associates with its ganglioside receptor GD1a
when this virus reaches the ER [10]. We postulate that SV40 is
next released into the lumen by detaching from GM1. Here it
undergoes conformational changes that enable the virus to re-
engage the ER membrane, ultimately penetrating this bilayer to
reach the cytosol. At steady state, there should be a virus pool
attached to GM1 on the ER membrane, in the ER lumen, trapped
on the ER membrane in the act of penetration, and in the cytosol.
Analyzing specific SV40 conformations in each pool should reveal
the sequence of events and the mechanism guiding membrane
penetration.
P1 in our assay ought to contain SV40 attached to GM1 on the
ER membrane (as well as on the plasma membrane and other
organelles), in the ER lumen, and trapped on the ER membrane
in transit to the cytosol. In contrast, S1 should contain virus that
reached the cytosol (or in transport vesicles at the earlier time
point). Because GM1 is enriched in membrane microdomains
referred to as lipid rafts [18], SV40 attached to GM1 should
localize to lipid rafts. Contents in this microdomain are often
found to be resistant to Triton X-100 extraction [21]. Thus, SV40
that reaches the ER but remains bound to GM1 is resistant to
Triton X-100 extraction, while those virus released into the ER
lumen or trapped on the ER membrane en route to the cytosol are
extracted by this detergent. Contents resistant to Triton X-100
extraction can be extracted by SDS.
Accordingly, P1 derived from cells incubated with SV40 for
varying times were solubilized with Triton X-100 (Figure 1C, step
2). After centrifugation, the resulting supernatant contains the
Triton X-100 extractable material (S2), while the new pellet
contains Triton X-100 insoluble material that was extracted by
SDS (P2). The S2 and P2 samples were subjected to immunoblot
analysis. We found that while VP1 is present in P2 throughout the
entire course of the experiment (Figure 2A, bottom panel, lanes 1–
7), VP1 only appeared in the S2 starting at 6 h.p.i. (Figure 2A, top
panel, compare lanes 4–7 to lanes 1–3). Under these conditions,
PDI and most of the ER membrane protein calnexin are found in
S2 but not P2 (Figure 2A, lane 9 and 10, compare top and bottom
panels), as expected for an ER lumenal and membrane protein not
enriched in lipid rafts.
VP1’s appearance in S2 derived from cells incubated with virus
for 12 hrs is blocked completely when cells are pretreated with
BFA (Figure 2A, top panel, compare lane 8 to 7). S2 VP1 also
decreased significantly if BFA is added 4 h.p.i. (Figure 2A, top
panel, compare lane 9 to 7), again demonstrating that BFA
blocked an intracellular step important for SV40 sorting to the
ER. As a control, we found that CTB, which is also found in lipid
raft-enriched membranes, remains exclusively in the P2 and not
S2 (Figure 2B, top panel, compare lane 2 to 1), indicating that
Triton X-100 did not non-specifically disrupt lipid raft membrane
domains to release SV40. These results demonstrate that ER
transport is required to generate Triton X-100-extractable virus,
consistent with the hypothesis that SV40 detaches from GM1
upon ER arrival. Thus, while SV40 in P2 represents virus
concentrated in membrane rafts due to its interaction with GM1,
SV40 in S2 represents virus that reached the ER and is released
into the ER lumen, either preparing for membrane penetration or
trapped on the ER membrane in transit to the cytosol. SV40’s
appearance in the ER starting at 6 h.p.i. in this assay is in
agreement with previous studies [12,18], and is consistent with the
notion that SV40 arrives in the cytosol after 6 h.p.i. (Figure S1E,
top panel).
P2, S2, and S1 contain SV40 at different stages of membrane
penetration. To examine the nature of SV40’s disulfide bonds in
these fractions, samples from the three fractions generated from
cells infected with SV40 for 12 hrs were subjected to non-
reducing SDS-PAGE followed by immunoblotting with VP1-
specific antibodies. VP1 monomer, dimer, and virus at top of the
gel were detected in P2 (Figure 2C, top panel, lane 1). In S2, a
faint species corresponding to a VP1 higher oligomer, dimer,
and more monomer (when compared to its P2 level) were
observed (Figure 2C, top panel, lane 2). By contrast, only VP1
monomer was detected in S1 (Figure 2C, top panel, lane 3).
When all three fractions were subjected to reducing SDS-PAGE,
VP1 monomer was the only species observed (Figure 2C, bottom
panel, lanes 1-3).
Thus, when the virus initially arrives in the ER attached to the
membrane, disulfide bond disruption is initiated, generating VP1
monomer and dimer (Figure 2C, lane 1). When the virus is
released into the ER lumen or becomes subsequently trapped on
the ER membrane en route to the cytosol, intact virus is converted
to the VP1 higher oligomer, and the dimer is further reduced to
the monomer (Figure 2B, compare lane 2 to 1). Finally, upon
cytosol arrival, complete disruption of the disulfide bonds ensues,
generating VP1 monomer (Figure 2B, compare lane 3 to 2). These
results demonstrate a sequential rearrangement of SV40’s disulfide
bonds as it moves from the ER to the cytosol. We note that as
monomer and dimer were not detected in any of the fractions
using non-SDS biochemical methods (below), they likely still
consist of VP1 pentamers that remain in contact with the core viral
particle via non-covalent interactions.
As complete disruption of disulfide bonds that generates VP1
monomer (in a non-reducing SDS condition) is a hallmark of
cytosol-localized SV40, we performed a time-course experiment
using a non-reducing SDS-PAGE and showed that VP1
monomer appeared in S1 at approximately 8 h.p.i. (Figure 2D,
lanes 5–7). These findings further support the assertion that SV40
begins to arrive to the cytosol sometime after 6 h.p.i., also
consistent with our measurement of SV40 ER arrival at
approximately 6 h.p.i.
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using conformation-specific antibodies
The disulfide bond arrangement of ER- and cytosol-localized
SV40 is distinct (Figure 2B, top panel, compare lane 2 to 3).
However, whether this difference affects the global viral conforma-
tion is unknown. We therefore evaluated the virus structures in S1
and S2 using four independent biochemical approaches.
We first used conformation-specific antibodies for this purpose.
Two monoclonal VP1 antibodies (CC10 and BC11) were shown to
neutralize SV40 infection, but did not recognize denatured virus
Figure 2. ER-localized SV40 is released into the ER lumen and undergoes sequential disulfide bond disruption. (A)Cells treated with or
without BFAat the indicated time points were infected with SV40 for varying amounts of time, harvested, andanalyzedaccording to Figure 1C.Samples
were immunoblottedwithantibodies againstVP1, PDI, or calnexin.(B)Cells were intoxicatedwith CTB for90 min, andprocessed accordingtoFigure 1C.
Samples were immunoblotted with antibodies against PDI, calnexin, and CTB. (C) Cells were infected with SV40 and harvested at 12 h.p.i. S1, S2, and P2
were prepared as in A and analyzed by non-reducing and reducing SDS-PAGE, followed by immnoblotting with antibodies against VP1. (D) Cells were
infected with SV40 for the indicated times, and S1 subjected to non-reducing SDS-PAGE followed by immunoblotting against VP1.
doi:10.1371/journal.ppat.1002037.g002
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precipitated the VP1 pentamer (not shown). Hence, the CC10 and
BC11 antibodies recognize structural features of the intact
pentamer, but not unfolded virus whose epitopes critical for
antibody recognition are disordered. We reasoned that, at a sub-
saturating antibody concentration where there is insufficient
antibody to bind to all available VP1, a given CC10 or BC11
antibody should precipitate more VP1 if the virus is assembled and
intact than disassembled and uncoated. In contrast, at a saturating
antibody concentration, a similar VP1 level would be precipitated
by the antibodies regardless of the viral structural state. Thus,
using antibodies at a sub-saturation condition could potentially
reveal the global structural state of SV40.
Accordingly, at 12 h.p.i., cells were subjected to the semi-
permeabilized assay, and virus in S1 and S2 immunoprecipitated
with a mixture of increasing amounts of the VP1 monoclonal
antibodies. VP1 in S1 precipitated less efficiently than VP1 in S2
when a low (i.e. 0.04 mg) level of antibodies was used (Figure 3A,
top panel, compare lane 1 to 4). However, the difference in the
precipitation efficiency gradually disappeared when higher levels
of antibodies (i.e. 0.2 and 1 mg) were used (Figure 3A, top panel,
compare lanes 2 and 3 to lanes 5 and 6). A control antibody did
not precipitate VP1 from S2 (Figure 3A, top panel, lane 8). Thus,
in our experimental conditions, 0.04 mg represents a sub-
saturating antibody concentration in which differences between
the structural organization of SV40 in S1 and S2 can be revealed.
Specifically, that 0.04 mg of the SV40 antibodies precipitated less
VP1 from S1 than S2 suggests that virus in S1 underwent
disassembly.
VP2/VP3 in S2 co-precipitated with VP1 specifically (Figure 3B,
top panel, compare lane 2 to 4), with an efficiency similar to that
observed when purified WT SV40 was used as the starting
material (Figure 3B, top panel, compare lane 2 to 6). In addition,
the SV40 genome also co-precipitated with VP1 from S2
specifically (Figure 3C, compare lane 2 to 4). In contrast, VP2
and VP3 in S1 co-precipitated weakly with VP1 when compared
to the efficiency observed using purified WT SV40 (Figure 3D, top
panel, compare lane 1 to 3), even when 5-fold more S1 than S2
was used for immunoprecipitation. The SV40 genome co-
precipitated with VP1 in S1 specifically (Figure 3E, compare lane
2 to 4). Our results suggest that the ER-localized SV40 is more
assembled and intact than the cytosol-localized virus, and retains
strong binding to the internal viral components. The cytosol-
localized virus likely experienced disassembly, and displays less
interaction with its internal proteins.
ER-localized SV40 is large, while those in the cytosol are
large and small
As a second method to probe SV40’s conformations in the ER
and cytosol, S1 and S2 prepared from cells infected with SV40 for
12 hrs were subjected to gel filtration analyses. Our data showed
that essentially all the viral particles in S2 are found in fractions
similar to purified WT SV40 (estimated to be .660 kDa in our
system due to resolution of the column) (Figure 4A, compare
second and third panels from top). For simplicity, these viral
particles are referred to as ‘‘large’’ particles (Figure 4A). In
contrast, a virus pool in S1 was found in fractions that
corresponded to ‘‘small’’ particles approximating 150 kDa, while
another portion was located in fractions corresponding to the large
particle (Figure 4A, top panel). The 150 kDa species likely
represents the VP1 pentamer. These results demonstrate that all
the SV40 particles in the ER are large, while virus in the cytosol
exists as large and small particles.
We next used continuous (20–40%) sucrose gradient sedimen-
tation as a third approach to examine SV40’s structure in the ER
and cytosol (Figure 4B). Again, whereas all the virus in S2
sedimented to bottom heavier fractions similar to purified WT
SV40 corresponding to the large particle (Figure 4B, compare
second and third panels from top), a portion of virus in S1 was
found in the top lighter fractions corresponding to the small
particle and another portion in the heavier fractions corresponding
to the large particle (Figure 4B, top panel). The virus remained in
these lighter fractions even when S1 was pretreated with Triton X-
100 prior to sedimentation (not shown), indicating that SV40 in
these fractions is not due to flotation caused by membrane
encapsulation. PCR analysis further demonstrated that the large
but not small viral particles in S1 contain the viral genome
(Figure 4C, compare bottom and top panels). This result is
consistent with our co-immunoprecipitation analysis demonstrat-
ing that the cytosol-localized SV40 binds to the genome
(Figure 3E).
To estimate the proportion of SV40 in S1 and S2 that are small
and large, these samples (along with purified WT SV40) were
layered over a sucrose cushion (20%) and centrifuged (Figure 4D).
The large particle is expected to penetrate the sucrose cushion and
sediment, while the small particles should remain near the top of
the cushion. When the sedimented material (labeled large) and
material near the top of the cushion (labeled small) were subjected
to immunoblotting, approximately 50% of virus in S1 were found
in the small fraction and 50% in the large fraction (Figure 4D,
compare lane 1 to 2). In contrast, essentially all of the virus in S2
and a sample containing purified WT SV40 was large (Figure 4D,
compare lane 4 to 3 and 6 to 5). This size distribution is consistent
with the gel filtration (Figure 4A) and continuous sucrose
sedimentation (Figures 4B and 4C) findings.
Results using four distinct biochemical strategies (i.e. immuno-
precipitation, gel filtration, continuous sucrose gradient sedimen-
tation, and sucrose cushion sedimentation) demonstrate unambig-
uously that SV40 in the ER is a large particle, while the virus in
the cytosol exists as small and large particles. The simplest
explanation of these findings is that ER-localized SV40 penetrates
the ER membrane as a large and intact particle, reaching the
cytosol where it disassembles into small particles. The remaining
core particle after cytosol-mediated disassembly, which remains
relatively large and cannot be distinguished from the large ER-
localized particle using either gel filtration or sucrose gradient
analysis, contains the genome and is likely the predecessor to the
form that enters the nucleus.
Alternatively, it is possible that the ER-localized large particle
disassembles into small particles in the ER, become discharged
into the cytosol where they re-assemble into a large particle. To
test whether the cytosol supports large particle assembly in our
system, we analyzed SV40 virion formation by transfecting cells
with the viral genome. Using this method, VP1 monomer should
be made in the cytosol, followed by its oligomerization into
pentamers in this compartment. The pentamers are expected to
import into the nucleus for full assembly into the large SV40
particle. We found that when cells were transfected with the
SV40 genome for 48 hrs, subjected to the semi-permeabilized
assay, and the S1 and P1 analyzed by sucrose gradient
sedimentation, only small particles were found in the S1
(Figure 4E, top panel, fractions 1–4). These small particles
represent the cytosol-localized pentamers. By contrast, VP1
appeared in virtually all fractions in the P1 (Figure 4E, bottom
panel). (The pellet was subjected to repeated freeze-thaw to
extract virus from the nucleus). VP1 in the top fractions
corresponds to nuclear-localized pentamers imported from the
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particles in the nucleus undergoing assembly. Thus, when cells
were transfected with the SV40 genome, VP1 pentamers are
generated in the cytosol and imported into the nucleus to form
large particles, consistent with the established SV40 assembly
process [20]. Importantly, these results demonstrate that the
cytosol does not support large particle formation from small
particles.
Figure 3. Immunoprecipitation of ER- and cytosol-localized SV40 using conformation-specific antibodies. (A) Cells were infected with
SV40 for 12 hrs, harvested, and processed according to Figure 1C to obtain S1 and S2. These fractions were incubated with the indicated VP1
antibody concentration, or a control antibody. The precipitated samples were subjected to SDS-PAGE followed by immunoblotting against VP1. 5%
input is shown. (B) S2 in A and WT SV40 were subjected to immunoprecipitation using either VP1 or a control antibody, and the precipitated sample
subjected to SDS-PAGE and immunoblotted with antibodies against VP2/VP3 or VP1. 5% input is shown. (C) The inputs and immunoprecipitates in B
were subjected to PCR to amplify a region of SV40 genome. 5% input is shown. (D) As in B, except the S1 was used for immunoprecipitation. (E) As in
C, except the S1 was used as the starting material.
doi:10.1371/journal.ppat.1002037.g003
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localized SV40
We next sought to visualize the large SV40 particle in the S1
cytosol. Buffer, WT SV40, S1 derived from mock-infected cells
(i.e. mock-infected S1), and S1 derived from SV40-infected cells
for 12 hrs (i.e. SV40-infected S1) were immunoprecipitated with
VP1-specific antibodies, and the immunoprecipitate captured by
magnetic beads. Samples were subjected to SDS-PAGE and silver
stained. A distinct band corresponding to VP1 was detected in
samples derived only from WT SV40 and SV40-infected S1
(Figure 5A, lanes 2 and 4). In addition, a band corresponding to
VP3 was also found in the WT SV40 and SV40-infected S1
immunoprecipitate (Figure 5A, lanes 2 and 4), consistent with the
co-immunoprecipitation result presented in Figure 3D. When the
immunoprecipitate derived from WT SV40 was subjected to
negative stain EM, a mostly homogenous population of spherical
particles approximately 50 nm could be seen (Figure 5B, a and b).
Interestingly, while spherical particles approximating 50 nm
could also be observed in the SV40-infected S1 immunoprecipitate
(Figure 5C, a and b (white arrow)), others appeared to be slightly
distorted, appearing as elongated spheres with what seems to be
pores in the middle (Figure 5C, b (white arrow head)). Even more
distorted SV40 particles around 50 nm could also be found in the
S1 immunoprecipitate. In these cases, some of their overall
structures were poorly defined (Figure 5D, a and d), while others
appeared again to be elongated spheres with a doughnut-shaped
pore in the middle (Figure 5D, c) or contained a clover leaf-shaped
hole (Figure 5D, b). Thus S1 SV40 particles are heterogeneous in
structure, and likely represent the large particle pool identified in
our biochemical assays.
Role of VP3 and viral genome in SV40 ER-to-cytosol
membrane transport
In addition to elucidating the ER membrane penetration
mechanism, we characterized the viral components regulating this
process. As VP2, VP3, and viral genome co-transport with VP1 to
the cytosol (Figure 1), we asked whether these internal components
control ER-to-cytosol transport. To address whether the minor
coat proteins play a role, we generated SV40 mutant viruses
lacking VP2 (SV40 (-VP2)), VP3 (SV40 (-VP3)), or both (SV40
(-VP2/-VP3)) (Figure 6A, top and bottom panel, compare lanes 2–
4 to 1). VP3’s band intensity is higher than VP2 in WT SV40
(Figure 6A, bottom panel, lane 1), indicating more VP3 than VP2
per viral particle, as reported previously [20].
We first determined whether the mutant viruses reach the ER
with equal efficiency as WT SV40 by assessing their ability to
undergo both ER-dependent disulfide disruption and release from
GM1-enriched lipid raft membranes. Cells were incubated with
WT or mutant SV40 for 6 hrs, and the S2 prepared. When S2 was
subjected to non-reducing SDS-PAGE, SV40 (-VP3) displayed a
similar VP1 banding pattern as WT SV40 (Figure 6B, compare
lane 3 to 1). In contrast, very low signal was detected in S2 derived
from cells infected with SV40 (-VP2) or SV40 (-VP2/-VP3)
(Figure 6B, compare lanes 4 and 2 to 1). As expected, when the S2
was subjected to reducing SDS-PAGE, a similar VP1 level was
seen between WT and SV40 (-VP3), and essentially no signal was
detected from samples derived from SV40 (-VP2) or SV40 (-VP2/
-VP3) (Figure 6C, compare lanes 1 and 3 to 2 and 4). The VP1
level was similar in all samples in the P2 (Figure 6C, lanes 5–8),
indicating that the total cell-associated virus is the same between
WT and mutant viruses. These results demonstrate that SV40
(-VP3), but not SV40 (-VP2) or SV40 (-VP2/-VP3), reaches the
ER with similar efficiency as WT SV40 at 6 h.p.i.; SV40 (-VP2)
and SV40 (-VP2/-VP3) likely entered the cells but failed to sort to
the ER.
We next asked whether the mutant viruses undergo ER-to-
cytosol transport by assessing the S1 VP1 level at both 8 and 12
h.p.i. using the semi-permeabilized system described in Figure 1.
We found that the S1 VP1 level for all mutant viruses decreased
significantly at both time points when compared to WT SV40
(Figure 6D, top and fourth panels, compare lanes 2–4 to 1). The
mutant viruses also promoted infection poorly when compared to
WT SV40 (Figure 6E). As SV40 (-VP3) reaches the ER from the
cell surface with similar efficiency as WT SV40 at 6 h.p.i., we
conclude that VP3 plays a critical role in ER-to-cytosol transport.
Because SV40 (-VP2) and SV40 (-VP2/-VP3) did not reach the
ER, they are expected to not undergo subsequent ER-to-cytosol
transport. Thus, our results cannot distinguish a role of VP2 in the
ER-to-cytosol penetration process. Of interest, VP2 and VP3 were
shown previously to be necessary for nuclear entry [23].
To address the viral genome’s role in facilitating ER exit of
SV40, we enriched for SV40 that lacked the genome (SV40
(-genome)) on a CsCl gradient. As expected, infection caused by
SV40 (-genome) was attenuated severely when compared to WT
SV40 (Figure 6F, approximately 9% of WT). When cells
incubated with this mutant virus for 12 hrs were subjected to
the semi-permeabilized assay, the S1 VP1 level decreased when
compared to the VP1 level derived from cells infected with WT
SV40 (Figure 6G, top panel, compare lane 2 to 1). SV40 (-genome)
and WT SV40 underwent similar ER-dependent disulfide
rearrangement (Figure 6H, compare lane 2 to 1) and release from
lipid raft membrane domains (Figure 6H, compare lane 4 to 3).
We conclude that in addition to VP3, the SV40 genome appears
to also mediate its ER-to-cytosol transport.
SV40 release into the cytosol depends on the host
proteasome
What might be the driving force that discharges SV40 into the
cytosol from the ER membrane? The proteasome has been shown
to extract some misfolded proteins from the ER membrane into
the cytosol [24,25]. As proteasome inhibition decreased SV40
infection [12], we tested the proteasome’s role in cytosol release of
SV40 by using MG132, a proteasome inhibitor. When DMSO or
MG132 was added simultaneously with SV40 to cells for 12 hrs,
VP1 in S1 decreased in cells treated with MG132 when compared
to DMSO (Figure 7A, top panel, compare lane 6 to 1; quantified
in Figure 7B). The VP1 level in S1 was restored to a similar level as
the DMSO-treated cells when MG132 was added increasingly
Figure 4. ER-localized SV40 is large, while cytosol-localized SV40 is large and small. (A) S1 and S2 derived from cells infected with SV40 for
12 hrs, and purified SV40, were subjected to gel filtration. Fractions were analyzed by SDS-PAGE, followed by immunoblotting with antibodies
against VP1. VP1 was detected in two peak fractions, ‘‘large’’ (fractions 13–15) and ‘‘small’’ (fractions 22–23). (B) S1, S2, and purified SV40 in A were
subjected to continuous sucrose gradient centrifugation and analyzed as in A. VP1 was mainly detected in two peak fractions, ‘‘small’’ (fractions 1–3)
and ‘‘large’’ (fractions 5–9). (C) S1 in A was subjected to sucrose gradient centrifugation. Fractions were analyzed as in A and subjected to PCR to
amplify a part of SV40 genome. (D) As in B, except samples were layered over a 20% sucrose cushion, centrifuged, and the sedimented material
(large) and material near the top of the cushion (small) was analyzed by immunoblotting. (E) Cells were transfected with an SV40 genome and
processed as in B, except the pellet was subjected to repeated freeze-thaw to extract the nuclear-localized virus.
doi:10.1371/journal.ppat.1002037.g004
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PLoS Pathogens | www.plospathogens.org 10 May 2011 | Volume 7 | Issue 5 | e1002037Figure 5. Negative stain EM of WT and cytosol-localized SV40. (A) Buffer, WT SV40, S1 derived from mock-infected cells (i.e. mock-infected
S1), and S1 derived from SV40-infected cells for 12 hrs (i.e. SV40-infected S1) were immunoprecipitated with VP1-specific antibodies, and the
immunoprecipitate captured by magnetic beads. Samples were subjected to SDS-PAGE and silver stained. (B) WT SV40 immunoprecipitate was
subjected to negative stain EM. Bar represents 50 nm. (C-D) SV40-infected S1 immunoprecipitate was subjected to negative stain EM. Bar represents
50 nm.
doi:10.1371/journal.ppat.1002037.g005
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PLoS Pathogens | www.plospathogens.org 11 May 2011 | Volume 7 | Issue 5 | e1002037Figure 6. Role of VP3 and viral genome in SV40 ER-to-cytosol membrane transport. (A) WT and mutant viruses lacking VP2, VP3, or both
were analyzed by immunoblotting with antibodies against VP1 and VP2/VP3. (B) Cells were infected with the indicated virus for 6 hrs, harvested, and
subjected to the semi-permeabilized assay to obtain S2. S2 was subjected to non-reducing SDS-PAGE followed by immunoblotting against VP1. (C)
As in B, except both S2 and P2 were prepared. Both fractions were subjected to reducing SDS-PAGE and immunoblotted with a VP1 antibody. (D)
Cells were infected with the indicated virus for either 8 or 12 hrs, harvested, and subjected to the ER-to-cytosol membrane penetration assay. S1 (60%
of total) and P1 (5% of total) were analyzed by SDS-PAGE, followed by immunoblotting with the indicated antibodies. (E) Cells were infected with the
indicated virus and analyzed as in Figure 1B. In a field of view, 467/471 cells scored TAg-positive using WT SV40, 26/387 cells using SV40 (-VP2), 0/375
using SV40 (-VP3), and 0/421 cells using SV40 (-VP2/-VP3). (F) The extent of TAg expression induced by WT and SV40 (-genome) was analyzed as in E.
In a field of view, 205/359 cells scored TAg-positive using WT SV40, and 17/379 cells using SV40 (-genome). m.o.i.=5 was used. (G) Cells were infected
with either WT SV40 or SV40 (-genome) for 12 hrs and analyzed as in D. (H) Cells were infected with either WT SV40 or SV40 (-genome) for 12 hrs, and
processed to obtain S2 and P2. S2 was subjected to both non-reducing and reducing SDS-PAGE, and P2 was subjected to reducing SDS-PAGE.
doi:10.1371/journal.ppat.1002037.g006
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compare lane 6 to lanes 2–5; quantified in Figure 7B). The time
range when proteasome inhibition no longer affects virus arrival to
the cytosol (i.e. approximately 9–11 h.p.i.) occurs slightly after
arrival of SV40 to the cytosol (i.e. approximately 8 h.p.i.). Addition
of epoxomicin, a more specific proteasome inhibitor, to cells also
decreased the S1 VP1 level at 12 h.p.i. (Figure 7C, top panel,
compare lane 2 to 1), consistent with the MG132 effects. These
findings indicate that the proteasome plays an important function
in promoting virus release into the cytosol.
MG132 decreased SV40 infection when this drug was added
simultaneously with SV40 to cells (Figure 7D, 0 h.p.i., compare
square to circle), similar to a previous finding [12]. The infection
level was restored partially if MG132 was added 9 or 11 h.p.i.
(Figure 7D, circles), consistent with restoration of the S1 VP1 level
when this drug was added at the same time points post-infection
(Figure 7A and 7B). The correlation between the time-dependent
effects of MG132 on viral infection and release into the cytosol
underscores the proteasome’s role in controlling SV40’s ER-to-
cytosol transport.
As inhibiting the proteasome prevents SV40 release into the
cytosol, we hypothesized that such perturbation should concom-
itantly cause an increase in ER-localized virus. To assess the ER-
localized SV40 level, we measured formation of viral disulfide
Figure 7. Release of SV40 into the cytosol depends on the host proteasome. (A) MG132 and DMSO were added to CV-1 cells at the
indicated post-infection time points and at 0 h.p.i., respectively. Cells were harvested at 12 h.p.i. and subjected to the ER-to-cytosol membrane
penetration assay. S1 was analyzed. (B) The VP1 band intensities in A were quantified with ImageJ (NIH). Data represent the mean +/2 SD of at least 3
independent experiments. (C) As in A except where indicated, cells were treated with epoxomicin or DMSO at 0 h.p.i. (D) Cells were infected with
SV40 and treated with MG132 or DMSO as in A, and analyzed as in Figure 1B. In a field of view, 320/359 cells scored TAg-positive in DMSO-treated
cells. In MG132-treated cells, 114/205 cells scored TAg-positive at 0 h.p.i., 111/188 cells at 3.5 h.p.i., 155/221 cells at 7 h.p.i., 193/279 cells at 9 h.p.i.,
and 250/333 cells at 11 h.p.i. (E) Cells treated with or without BFA or MG132 were infected with SV40 for 12 hrs, processed to obtain the S2 and P2,
and the sample subjected to non-reducing SDS-PAGE followed by immunoblotting against VP1.
doi:10.1371/journal.ppat.1002037.g007
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for 12 hrs and subjected to the semi-permeabilized assay. The
resulting P1 was used to generate S2 and P2. These fractions were
subjected to non-reducing SDS-PAGE followed by immunoblot-
ting with VP1-specific antibodies. We detected formation of VP1
monomer, dimer, and a low level of the higher oligomer in the S2
(Figure 7E, left panel, lane 2). BFA added at infection blocked the
generation of these products (Figure 7E, left panel, compare lane 2
to 1), consistent with results observed in a WCE sample
(Figure 1A). When cells were incubated simultaneously with
MG132 and SV40, the VP1 monomer, dimer, and higher
oligomer levels in the S2 increased when compared to control
cells (Figure 7E, left panel, compare lane 3 to 2). Similarly,
proteasome inhibition also increased VP1 monomer in P2 when
analyzed by a non-reducing gel (Figure 7E, right panel, compare
lane 6 to 5). Thus blocking the proteasome activity caused a build-
up of virus in the ER lumen and those that remained attached to
GM1 on the ER membrane. These findings further demonstrate a
role of the proteasome in controlling exit of SV40 to the cytosol.
Discussion
How non-enveloped viruses penetrate biological membranes is
understood poorly [2]. Here we established a cell-based assay to
examine ER-to-cytosol membrane transport of the non-enveloped
SV40. Our findings drew four major conclusions, depicted in
Figure 8. First, upon ER arrival, SV40 attached to GM1 on the
ER membrane is released into the ER lumen, and undergoes
sequential disulfide bond disruption to reach the cytosol (steps 1
and 2). Disulfide bond disruption triggers conformational changes
that prime the virus for membrane penetration (step 3). This step
may involve VP2 and VP3 exposure. Second, despite ER
remodeling events, a large and intact viral particle penetrates
the ER membrane to reach the cytosol, potentially through either
the lipid bilayer (step 4a) or a sizeable protein-channel (step 4b).
Third, viral VP3 and potentially the genome, as well as the host
proteasome, regulate SV40 release into the cytosol (step 5). And
fourth, SV40 disassembles in the cytosol (step 6). We will discuss
these points separately.
SV40 in the ER
Using a semi-permeabilized system, we found that SV40 is
released into the ER lumen upon ER arrival, presumably by
detaching from GM1. What might be the driving force for this
reaction? ER factors may induce physical changes to VP1 that
decreases its affinity for GM1. Alternatively, when GM1 reaches
the ER, it may partition into the ER bilayer, thereby reducing
SV40’s affinity for the membrane.
In the ER, disruption of SV40’s disulfide bonds by the PDI
family members ERp57 and PDI imparts conformational changes
on the viral particle, priming it for membrane penetration [12].
Using non-reducing SDS-PAGE, our analyses dissected this
reaction into several steps. First, when SV40 attached to GM1
reaches the ER, its disulfide bonds are disrupted, generating VP1
monomer and dimer. Next, when the virus is released into the ER
lumen, monomer and dimer, as well as a higher oligomer (which
could be an intermediate for the dimer and monomer) continues to
form. Because only a large viral particle was detected in the ER
using non-SDS methods, disulfide bond disruption is not sufficient
Figure 8. Model of SV40 penetration across the ER membrane (See text for discussion).
doi:10.1371/journal.ppat.1002037.g008
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likely represents VP1 pentamers that remain attached to the core
viral particle via non-covalent interactions.
Finally, when the virus is discharged into the cytosol, all the
intermediate species undergo a thorough disruption of the disulfide
bonds to produce only VP1 monomer. During these steps, SV40’s
interchain Cys9-Cys9 and Cys104-Cys104 disulfide bonds [4,12]
are likely disrupted. As a species resembling VP1 pentamer (but
not monomer) is detected in the cytosol using non-SDS methods,
the monomer must be held together non-covalently. The
sequential manner by which SV40’s disulfide bonds are disrupted
as it moves from the ER into the cytosol reveals the coordinated
manner by which the host dismantles the virus.
A large and intact SV40 penetrates the ER membrane
Using four independent biochemical approaches, our results
unambiguously established that the conformations of the ER- and
cytosol-localized viral particles are different. Specifically, we
demonstrate that ER-localized SV40 is large and intact, and
contains VP2, VP3, and the genome. No small viral particles were
detected in the ER. In contrast, both large and small viral particles
are present in the cytosol. These particles display weak VP1-VP2/
VP3 binding. Furthermore, our EM analyses detected large 50 nm
viral particles in the cytosol, although they appear to be
heterogeneous in structure. The simplest interpretation of these
data is that a large and intact viral particle in the ER penetrates
the ER membrane to reach the cytosol where it disassembles.
Another potential explanation is that the ER-localized large
particle disassembles to small particles that then discharge rapidly
to the cytosol where they re-assemble into a large particle.
However, this complex scenario is unlikely because it would
require an unprecedented efficiency in removing all the small
particles from the ER to the cytosol to preclude their detection in
the ER. Moreover, it is also inconsistent with the established SV40
assembly process in which the nucleus but not the cytosol supports
large virion assembly [20]. In our system, we further demonstrate
that the cytosol does not provide an environment conducive for
large particle assembly.
While a precise measurement of the large membrane penetrat-
ing species is not available, sucrose gradient analyses indicate that
its size is similar to the native 50 nm SV40 virion. This proposed
size raises the question of whether the virus crosses a protein-
conducting channel or the ER lipid bilayer. A previous study
implicated a role of Derlin-1, a component of an ER membrane
complex used during ERAD [26], in SV40 infection [12]. Should
Derlin-1 function as a channel, massive Derlin-1 oligomerization is
required to accommodate viral transport. That biological
membranes can support transport of large complexes is not
without precedent, as a 9 nm gold particle decorated with the
peroxisome-targeting signal can be transported into the peroxi-
some interior [27].
An alternative to the protein channel-based mechanism is a
lipid-based strategy. Our in vitro findings on mPy provide insight
into how this process may occur. The PDI family member ERp29
untangles the VP1 C-terminal arm of mPy in a reaction that
requires reduction of the virus disulfide bonds and removal of the
virus-bound calciums [28]. VP2 and possibly VP3 are then
exposed, generating a hydrophobic viral particle that binds,
integrates, and perforates the ER membrane [28,29]. These
reactions initiate mPy’s penetration across the ER lipid bilayer.
Interestingly, a different version of the lipid-based model was
hypothesized [30]. In this model, a pore in the ER membrane
created when a lipid droplet leaves the membrane enables SV40/
mPy to gain access to the cytosol. No experiments have validated
this idea thus far.
Role of viral and host components in regulating ER
membrane penetration
While SV40 VP2 and VP3 have been implicated in nuclear
entry [23], our findings demonstrate that at least VP3 plays a role
in SV40’s ER-to-cytosol transport; our results cannot distinguish
any function of VP2 in this process. In vitro, SV40 VP2 and VP3
can integrate into the ER membrane [31]. Integration of these
proteins into the ER membrane may create a pore through which
the viral genome is injected [31]. Alternatively, VP2 and VP3 may
act as lytic factors [32], perforating the ER membrane to allow
passage of a subviral particle. As the ER and nuclear membranes
are continuous, a subviral particle could bypass the cytosol and
reach the nucleus directly after penetrating the ER membrane.
However, the findings that cytosol arrival is required for SV40
infection [33], that interaction between VP3’s nuclear localization
signal and importins is necessary for nuclear entry [34], and that
ER machineries dedicated to ERAD are crucial for infection [12],
point to the ER-to-cytosol transport pathway as the dominant
infectious route. As SV40’s genome stabilizes its overall viral
architecture [12], its absence likely destabilizes the virus structure.
This could in turn lead to incorrect conformational changes that
perturb ER-to-cytosol transport.
The host proteasome also plays a pivotal function in controlling
SV40’s ER-to-cytosol transport. Since the proteasome extracts
some misfolded ER proteins to the cytosol [24,25], it may also
discharge SV40 into the cytosol. Establishing a cell-free reconsti-
tuted system will reveal if the proteasome plays a direct role in viral
release.
Our data also suggest that VP2 controls SV40 sorting to the ER
from the cell surface. In addition, VP3 may also be involved in this
process, should an SV40 mutant virus lacking VP3 reach the ER
inefficiently after 6 h.p.i.. Further experiments are required to
clarify how VP2 regulates ER sorting, and whether VP3 plays any
role.
Cytosol disassembly
Our analyses demonstrated that SV40 disassembles in the
cytosol. The starting substrate for this reaction is a large particle
that reaches the cytosol from the ER. Indeed, large particles
approximating 50 nm were detected in the cytosol by EM. Their
heterogeneous nature may reflect the various disassembly
intermediates. Of particular interest is the viral intermediate
containing a doughnut-shaped pore in the middle of its structure.
This species might represent a viral particle in which a 5-
coordinated VP1 pentamer is released to generate a pore. Release
of the 5-coordinated VP1 pentamer from intact SV40 in vitro was
previously hypothesized to be involved in ER-to-cytosol transport
[12].
Our biochemical results also show that the large cytosol-
localized virus disassembles to generate small particles approxi-
mating the size of a pentamer and lacks the genome. This
disassembly reaction may be aided by the low calcium concen-
tration in the cytosol which would promote loss of calcium ions
from the cytosol-localized virus, thereby further destabilizing VP1
capsomer interaction. The remaining core particle (relatively large
particle in Figure 8), which harbors the genome, is likely targeted
to the nucleus to cause infection. As the cytosol-localized viral
intermediates observed by EM are large, they are unlikely the
species that enter the nucleus. Because previous studies showed
that Hsp70 uncoats mPy in vitro [35] and binds to SV40 in cells
[36], this cytosolic chaperone may convert the large SV40 particle
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coupled to nuclear entry is unknown, and unraveling it will
provide insight into another critical step in SV40’s infection
pathway.
Materials and Methods
Materials
Polyclonal antibodies against Hsp90 and PDI were purchased
from Santa Cruz Biotechnology, monoclonal antibodies against
PDI from Abcam, large T antigen from Santa Cruz Biotechnol-
ogy, MG132 and epoxomicin from EMD chemicals, BFA from
Epicenter, proteinase K and monoclonal antibodies against HA
from Roche, and TCEP from Thermo Scientific. All other
reagents were from Sigma. The pUCSV40 encoding SV40
genome and polyclonal antibodies against VP1 were generous
gifts from Dr. H. Handa (Tokyo Institute of Technology),
polyclonal antibodies against VP3 from Dr. H. Kasamatsu
(University of California, Los Angeles) and monoclonal antibodies
against VP1 from Dr. W. Scott (University of Miami).
ER-to-cytosol membrane penetration assay
CV-1 cells were incubated with SV40 (m.o.i.=3–50) at 4uC,
washed, and incubated at 37uC. At indicated time points, cells
were trypsinized (scraped off for the mutant viruses), permeabi-
lized with HN buffer (50 mM Hepes, pH 7.5, 150 mM NaCl,
and protease inhibitors) containing 0.1% digitonin on ice for
10 min, and centrifuged at 16,100 g for 10 min. The resulting
supernatant is referred as S1. The pellet was resuspended in SDS
sample buffer and is referred as P1. Where indicated, P1 was
incubated in HN buffer containing 1% Triton X-100 on ice for
10 min and centrifuged at 16,100 g for 10 min. This second
supernatant is referred as S2. The Triton X-100-insoluble pellet
was resuspended in SDS sample buffer and is referred to as P2.
For non-reducing SDS-PAGE, NEM (10 mM) was added to all
buffers.
Immunoprecipitation
SV40 monoclonal antibodies (CC10 and BC11) or an HA
monoclonal antibody were added to S1 and S2 and incubated on
ice for 3 hrs. Protein G-Dynabeads (Invitrogen) were used to
capture the antibody-virus complex. The beads were isolated
using a magnet stand (Dynal), washed with a high salt buffer
(50 mM Hepes, pH 7.5, 500 mM NaCl, 1% Triton X-100), and
the bound proteins eluted with an acidic buffer (50 mM glycine,
pH 2.8).
Infection
CV-1 cells were incubated with the indicated viruses at 4uC for
2 hrs. The cells were washed and incubated at 37uC. 24 h.p.i.,
cells were fixed with 1% paraformaldehyde, treated with 0.2%
Triton X-100, and incubated in 3% milk. The cells were stained
with a mouse monoclonal SV40 large T antigen antibody,
followed by Alexa Fluor-488-conjugated secondary antibody
(Invitrogen). In each experiment, approximately 1,000 cells were
counted to assess the extent of large T antigen expression.
Gel filtration
S1 and S2 were loaded onto a Bio-Sil 600 gel filtration column
(Bio-Rad) and separated with HN buffer. Forty fractions (0.5 ml
each) were collected and 0.1 ml of fractions 9-30 was separated by
SDS-PAGE, followed by immunoblotting with VP1 monoclonal
antibodies.
Continuous sucrose gradient
S1 and S2 were loaded onto a 0.5 ml preformed 20–40%
sucrose gradient and centrifuged at 49,500 rpm for 50 min at 4uC
in an SW 55Ti rotor. After centrifugation, 10 fractions were
collected from the top.
Sucrose cushion sedimentation
S1, S2, and WT SV40 were layered over a 20% sucrose
solution, centrifuged, and the sedimented material and material
near the top of the cushion were subjected to immunoblotting.
SV40 transfection
Cells were transfected (Lipofectamine 2000, Invitrogen) with the
SV40 genome for 48 hrs, harvested, and subjected to the ER-to-
cytosol assay to generate S1 and P1. P1 was freeze-thawed to
extract virus from the nucleus. Both fractions were analyzed by
sucrose gradient sedimentation.
Preparation of WT and mutant SV40
WT and SV40 mutants were purified using the OptiPrep
gradient system, except SV40 (-genome) was purified by CsCl
gradient. Briefly, SV40-infected or viral genome-transfected CV-1
cells were lysed in a buffer containing 50 mM Hepes (pH 7.5),
150 mM NaCl, and 0.5% Brij58 on ice for 30 min and
centrifuged at 16,100 g for 10 min. The supernatant was loaded
onto a discontinuous 20 and 40% OptiPrep gradient and
centrifuged at 49,500 rpm for 2 hrs at 4uC in an SW 55Ti rotor.
A viral particle fraction between 20% and 40% OptiPrep was
collected with a needle. For separation of virion and empty
particle, supernatant was loaded onto a 1.516, 1.443, 1.37, 1.296,
1.222, and 1.148 g/ml discontinuous CsCl gradient (1 ml each)
and centrifuged at 35,000 rpm for 3 hrs at 4uC in an SW 41Ti
rotor. Fractions corresponding to virion and empty particle were
collected. Each fraction was transferred into a 5641-mm open-top
tube (Beckman) and centrifuged at 49,500 rpm for 12 hrs at 4uC
in an SW 55Ti rotor. A fraction corresponding to virion or empty
particle was collected.
Biotinylated SV40
Purified SV40 was labeled with EZ-Link Sulfo-NHS-LC-Biotin
(Thermo) according to the manufacturer’s protocol.
siRNA knock-down
33 nM ERp57-specific (59-UGAAGGUGGCCGUGAAUUA-
TT-39) (Invitrogen) or control (Ambion) siRNAs were transfected
into CV-1 cells using the Lipofectamine 2000 system according to
the manufacturer’s protocol. At 36 hrs post-infection, cells were
infected with SV40 at m.o.i.=5 and subjected to the ER-to-
cytosol membrane penetration assay.
Viral genome detection by PCR
Samples from S1, immunoprecipitation, or sucrose gradient
fractions were incubated in 10 mM Tris-HCl (pH 8.5) containing
0.2 mg/ml proteinase K. After proteinase K was heat-inactivated,
the samples were subjected to a PCR reaction using a set of
primers (GCAGTAGCAATCAA CCCACA [forward] and
CTGACTTTGGAGGCTTCTGG [reverse]).
ER co-localization
CV-1 cells plated on 18 mm glass plates were washed with
DMEM, chilled at 4uC, and incubated with SV40 (m.o.i.=1) at
4uC for 1 hr. Cells were washed extensively to remove unbound
viruses, incubated in DMEM at 37uC for 10 hrs, fixed with 1%
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VP1 and rabbit polyclonal PDI antibody, followed by an Alexa
Fluor 594 and Rhodamine conjugated secondary antibodies.
Images were taken with an Olympus FV-500 confocal microscopy
equipped with 100x objective. The ER images derived from the
PDI signal were subjected to the FFT Bandpass Filter embedded
in Image J (NIH) as described previously [36].
Trypsin digestion analysis
4-fold more S1 at 4 h.p.i. was used to ensure that the VP1 level
is similar between S1 at 4 and 12 h.p.i. The samples were
incubated with 30 or 100 mg/ml trypsin for 1 hr on ice and the
reaction was stopped by the addition of 1 mM TLCK for 10 min
on ice. The samples were separated by SDS-PAGE followed by
immunoblotting with SV40 VP1 monoclonal antibodies.
OptiPrep flotation assay
S1 or purified SV40 was mixed with the same amount of 60%
OptiPrep solution. 100 ml of the mixed sample was placed at the
bottom of a Beckman centrifuge tube (7620 mm), and 100 mlo f
20% OptiPrep was loaded onto the sample. The tube was
centrifuged in a Beckman TLA100 rotor for 1 hr at 100,000 rpm.
Fractions were collected from the top (20 ml each), separated by
SDS-PAGE, and immunoblotted with SV40 VP1 monoclonal
antibodies.
CT intoxication
CV-1 cells were intoxicated with 30 nM CT and subjected to
semi-permeabilization with 0.1% digitonin as described in the ER-
to-cytosol membrane penetration assay. S1 and P1 fractions were
analyzed by SDS-PAGE followed by immunoblotting with CTA,
PDI, and Hsp90 antibodies.
Isolation of CT in vesicles
Cells were washed with DMEM, chilled at 4uCi n1 0m lo f
DMEM for 20 min, and incubated with 30 nM CT at 4uCf o r
2 hrs. Cells were then washed with cold PBS to remove unbound
CT and incubated in 10 ml of DMEM at 37uC to allow entry. At
the indicated time points, cells were washed with cold PBS,
scraped off the plate in 1 ml of PBS containing 10 mM NEM,
and collected in a microcentrifuge tube. S1, prepared as
described above, was incubated with or without 2% SDS at
25uC for 10 min. The samples were subjected to high-speed
centrifugation in a Beckman TLA100 rotor for 30 min at
100,000 g. The resulting supernatant and pellet fractions after
high-speed spin, and the original S1, were analyzed by SDS-
PAGE followed by immunoblotting with polyclonal CTB
antibodies.
Negaive stain electron microscopy (EM)
S1, prepared from cells (7.5610
6 cells) infected with SV40 for
12 hrs, was incubated with 1% Triton X-100 to solubilize any
membrane material, centrifuged in a Beckman TLA100 rotor for
30 min at 100,000 g to concentrate the virus, the resulting pellet
resuspended in 100 ml of HN buffer, and subjected to immuno-
precipitation as described above. The virus-antibody-bead com-
plex was captured by a magnet stand (Dynal) and washed with HN
buffer containing 1% Triton X-100. The magnetic beads were
resupended in 20 ml of HN buffer. For negative staining, 5 mlo f
each sample containing magnetic beads were absorbed onto a
grow-discharged copper grid (Electron Microscopy Sciences) and
stained with 1% uranyl acetate. The samples were observed using
a Philips CM-100 at 80 kV.
Supporting Information
Figure S1 Additional characterization of the ER-to-cytosol
penetration assay. (A) SV40-infected cells were treated with or
without BFA 4 h.p.i., and infection continued for 8 more hrs.
WCE was prepared and analyzed by non-reducing and reducing
SDS-PAGE, and immunoblotted with an antibody against VP1.
(B) Cells plated on 18 mm glass plates were washed with
DMEM, chilled at 4uC, and incubated with SV40 (m.o.i.=1) at
4uC for 1 hr. Cells were then washed extensively to remove
unbound viruses, incubated in DMEM at 37uC for 10 hrs, fixed
with 1% paraformaldehyde, incubated with a mouse monoclonal
SV40 VP1 and rabbit polyclonal PDI antibody, followed by
an Alexa Fluor 594 and Rhodamine conjugated secondary
antibodies. Images were taken with an Olympus FV-500
confocal microscopy equipped with 100x objective. White arrow
head represents SV40 particle that co-localized completely with
the ER, while white arrow represents those virus that either did
not co-localize with the ER or co-localized with the ER
partially. (C) Cells were subjected to the semi-permeabilized
fractionation method to generate S1 and P1. These fractions
were subjected to SDS-PAGE followed by immunoblotting using
antibodies against Hsp90 and actin. (D) Cells treated with or
without BFA at intoxication were incubated with CT for
90 min. Cells were then subjected to the semi-permeabilized
assay to generate S1 and P1. These fractions were subjected to
SDS-PAGE followed by immunoblotting against the indicated
antibodies. (E) Cells were incubated with SV40 for the indicated
amount of time and processed according to the ER-to-cytosol
transport assay to generate S1. Samples were subjected to SDS-
PAGE and immunoblotted with the indicated antibodies. (F)
Cells incubated with CTB for 5 or 90 min were processed
according to the semi-permeabilized assay to generate S1. S1
was treated with or without SDS and centrifuged at high-speed
(100,000 g) to produce a supernatant (sn) and pellet fraction. S1,
sn, and pellet fractions were subjected to SDS-PAGE followed
by immunoblotting using an antibody against CTB. (G) S1 was
generated from cells infected with SV40 for 4 or 12 hrs. S1 were
treated with or without the indicated trypsin concentration and
subjected to SDS-PAGE followed by immnoblotting with an
antibody against VP1. 4-fold more S1 derived from cells infected
with SV40 for 4 hrs when compared to 12 hrs were used. (H) S1
samples in G, as well as WT SV40, were subjected to OptiPrep
gradient flotation. Individual fractions were subjected to SDS-
PAGE followed by immunoblotting against VP1. (I) Cells
infected with the indicated SV40 concentration for 12 hrs were
processed according to the semi-permeabilized assay to generate
S1 and P1. These fractions were subjected to SDS-PAGE
followed by immunoblotting using the indicated antibodies.
(graph) Infection studies using the different SV40 concentrations
were performed according to Figure 1B. In a field of view, 156/
372 cells scored TAg-positive at m.o.i.=3, 167/297 cells at
m.o.i.=5, 314/427 cells at m.o.i.=10, 355/415 cells at
m.o.i.=30, and 350/371 at m.o.i.=50. (J) Cells treated with
or without DTT (1 mM) were infected with SV40 for 12 hrs
and processed according to the semi-permeabilized assay to
generate S1 and P1. These fractions were subjected to SDS-
PAGE followed by immunoblotting using the indicated anti-
bodies. (graph) Infection studies wee performed according to
Figure 1B. In a field of view, 384/456 cells scored TAg-positive
in control cells, and 111/333 cells TAg-positive in DTT-treated
cells. (K) Cells treated with or without BFA were infected with
SV40 labeled with biotin for 12 hrs. The cells were processed
according to the semi-permeabilized assay to generate S1 and
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immunoblotting using the indicated antibodies.
(TIF)
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